282 related articles for article (PubMed ID: 23827542)
1. Encapsulation of Ellipticine in poly-(3-hydroxybutyrate-co-3-hydroxyvalerate) based nanoparticles and its in vitro application.
Masood F; Chen P; Yasin T; Fatima N; Hasan F; Hameed A
Mater Sci Eng C Mater Biol Appl; 2013 Apr; 33(3):1054-60. PubMed ID: 23827542
[TBL] [Abstract][Full Text] [Related]
2. Molecular binding of self-assembling peptide EAK16-II with anticancer agent EPT and its implication in cancer cell inhibition.
Lu S; Wang H; Sheng Y; Liu M; Chen P
J Control Release; 2012 May; 160(1):33-40. PubMed ID: 22465389
[TBL] [Abstract][Full Text] [Related]
3. Preparation, characterization and evaluation of antibacterial properties of epirubicin loaded PHB and PHBV nanoparticles.
Perveen K; Masood F; Hameed A
Int J Biol Macromol; 2020 Feb; 144():259-266. PubMed ID: 31821825
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of poly-(3-hydroxybutyrate-co-12 mol % 3-hydroxyvalerate) by Bacillus cereus FB11: its characterization and application as a drug carrier.
Masood F; Chen P; Yasin T; Hasan F; Ahmad B; Hameed A
J Mater Sci Mater Med; 2013 Aug; 24(8):1927-37. PubMed ID: 23674059
[TBL] [Abstract][Full Text] [Related]
5. Nanoparticulate fingolimod delivery system based on biodegradable poly (3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV): design, optimization, characterization and in-vitro evaluation.
Rezaie Shirmard L; Bahari Javan N; Khoshayand MR; Kebriaee-Zadeh A; Dinarvand R; Dorkoosh FA
Pharm Dev Technol; 2017 Nov; 22(7):860-870. PubMed ID: 26555615
[TBL] [Abstract][Full Text] [Related]
6. Microencapsulation of antibiotic rifampicin in poly(3-hydroxybutyrate-co-3-hydroxyvalerate).
Durán N; Alvarenga MA; Da Silva EC; Melo PS; Marcato PD
Arch Pharm Res; 2008 Nov; 31(11):1509-16. PubMed ID: 19023549
[TBL] [Abstract][Full Text] [Related]
7. Polymer-lipid-PEG hybrid nanoparticles as photosensitizer carrier for photodynamic therapy.
Pramual S; Lirdprapamongkol K; Svasti J; Bergkvist M; Jouan-Hureaux V; Arnoux P; Frochot C; Barberi-Heyob M; Niamsiri N
J Photochem Photobiol B; 2017 Aug; 173():12-22. PubMed ID: 28554072
[TBL] [Abstract][Full Text] [Related]
8. [Preparation and characterization of prednisolone-poly (hydroxybutyrate-co-hydroxyvalerate) nanoparticles].
Chen JH; Shagufta M; Davis SS
Yao Xue Xue Bao; 2002 Jun; 37(6):473-6. PubMed ID: 12579810
[TBL] [Abstract][Full Text] [Related]
9. Biomedical Applications of the Biopolymer Poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV): Drug Encapsulation and Scaffold Fabrication.
Rodríguez-Cendal AI; Gómez-Seoane I; de Toro-Santos FJ; Fuentes-Boquete IM; Señarís-Rodríguez J; Díaz-Prado SM
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511432
[TBL] [Abstract][Full Text] [Related]
10. Fabrication of long-acting insulin formulation based on poly (3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV) nanoparticles: preparation, optimization, characterization, and in vitro evaluation.
Bayrami S; Esmaili Z; SeyedAlinaghi S; Jamali Moghadam SR; Bayrami S; Akbari Javar H; Rafiee Tehrani M; Dorkoosh FA
Pharm Dev Technol; 2019 Feb; 24(2):176-188. PubMed ID: 29557733
[TBL] [Abstract][Full Text] [Related]
11. Amorphous amphiphilic P(3HV-co-4HB)-b-mPEG block copolymer synthesized from bacterial copolyester via melt transesterification: nanoparticle preparation, cisplatin-loading for cancer therapy and in vitro evaluation.
Shah M; Ullah N; Choi MH; Kim MO; Yoon SC
Eur J Pharm Biopharm; 2012 Apr; 80(3):518-27. PubMed ID: 22178562
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and characterization of collagen grafted poly(hydroxybutyrate-valerate) (PHBV) scaffold for loading of bovine serum albumin capped silver (Ag/BSA) nanoparticles in the potential use of tissue engineering application.
Bakare RA; Bhan C; Raghavan D
Biomacromolecules; 2014 Jan; 15(1):423-35. PubMed ID: 24328214
[TBL] [Abstract][Full Text] [Related]
13. Improving hydrophilicity, mechanical properties and biocompatibility of poly[(R)-3-hydroxybutyrate-co-(R)-3-hydroxyvalerate] through blending with poly[(R)-3-hydroxybutyrate]-alt-poly(ethylene oxide).
Li X; Liu KL; Wang M; Wong SY; Tjiu WC; He CB; Goh SH; Li J
Acta Biomater; 2009 Jul; 5(6):2002-12. PubMed ID: 19251499
[TBL] [Abstract][Full Text] [Related]
14. Effect of organosoluble salts on the nanofibrous structure of electrospun poly(3-hydroxybutyrate-co-3-hydroxyvalerate).
Choi JS; Lee SW; Jeong L; Bae SH; Min BC; Youk JH; Park WH
Int J Biol Macromol; 2004 Aug; 34(4):249-56. PubMed ID: 15374681
[TBL] [Abstract][Full Text] [Related]
15. Nuclear targeting peptide-modified, DOX-loaded, PHBV nanoparticles enhance drug efficacy by targeting to Saos-2 cell nuclear membranes.
Şahin A; Eke G; Buyuksungur A; Hasirci N; Hasirci V
J Biomater Sci Polym Ed; 2018 Apr; 29(5):507-519. PubMed ID: 29297759
[TBL] [Abstract][Full Text] [Related]
16. Preparation and evaluation of cytotoxic potential of paclitaxel containing poly-3-hydroxybutyrate-co-3-hydroxyvalarate (PTX/PHBV) nanoparticles.
Aslam A; Berger MR; Ullah I; Hameed A; Masood F
Braz J Biol; 2023; 83():e275688. PubMed ID: 37970904
[TBL] [Abstract][Full Text] [Related]
17. Development of a novel biocompatible poly(ethylene glycol)-block-poly(γ-cholesterol-L-glutamate) as hydrophobic drug carrier.
Ma Q; Li B; Yu Y; Zhang Y; Wu Y; Ren W; Zheng Y; He J; Xie Y; Song X; He G
Int J Pharm; 2013 Mar; 445(1-2):88-92. PubMed ID: 23376505
[TBL] [Abstract][Full Text] [Related]
18. Long-circulating polyhydroxybutyrate-co-hydroxyvalerate nanoparticles for tumor targeted docetaxel delivery: Formulation, optimization and in vitro characterization.
Vardhan H; Mittal P; Adena SK; Mishra B
Eur J Pharm Sci; 2017 Mar; 99():85-94. PubMed ID: 28002762
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial and cell viability measurement of bovine serum albumin capped silver nanoparticles (Ag/BSA) loaded collagen immobilized poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV) film.
Bakare R; Hawthrone S; Vails C; Gugssa A; Karim A; Stubbs J; Raghavan D
J Colloid Interface Sci; 2016 Mar; 465():140-8. PubMed ID: 26674229
[TBL] [Abstract][Full Text] [Related]
20. Hydrocortisone loaded poly-(3-hydroxybutyrate-co-3-hydroxyvalerate) nanoparticles for topical ophthalmic administration: Preparation, characterization and evaluation of ophthalmic toxicity.
Álvarez-Álvarez L; Barral L; Bouza R; Farrag Y; Otero-Espinar F; Feijóo-Bandín S; Lago F
Int J Pharm; 2019 Sep; 568():118519. PubMed ID: 31310791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
